Edward Nash Score: 47
Analyst at
Canaccord Genuity
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+48.5%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
63%
10 W / 6 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
73%
8 W / 3 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
27%
3 W / 8 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
27%
3 W / 8 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
54%
7 W / 6 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
63%
10 W / 6 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| May 26, 2026 |
Connect Biopharma Holdings Ltd - ADR
CNTB
|
BUY |
$6.00
Est. +155%
|
$2.35 | $2.72 |
Pending
|
$2.12
-9.8%
|
| May 06, 2026 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$106.00
Est. +28%
|
$82.71 | $89.46 |
Pending
|
$86.21
+4.2%
|
| Jan 08, 2026 |
Ventyx Biosciences Inc
VTYX
|
BUY |
$14.00
Est. +2%
|
$13.73 | $14.07 |
Bullseye Hit (±1%)
|
$14.00
+2.0%
|
| Jan 02, 2026 |
Corcept Therapeutics Inc
CORT
|
BUY |
$99.00
Est. +168%
|
$36.90 | $84.79 |
Pending
|
$82.91
+124.7%
|
| Nov 12, 2025 |
Viking Therapeutics Inc
VKTX
|
BUY |
$107.00
Est. +164%
|
$40.60 | $43.15 |
Pending
|
$28.75
-29.2%
|
| Oct 29, 2025 |
Viking Therapeutics Inc
VKTX
|
BUY |
$106.00
Est. +203%
|
$34.93 | $43.15 |
Pending
|
$28.75
-17.7%
|
| May 02, 2025 |
Madrigal Pharmaceuticals Inc
MDGL
|
BUY |
$420.00
Est. +33%
|
$315.48 | $615.00 |
Target Met
|
$480.77
+52.4%
|
| Aug 15, 2024 |
Corcept Therapeutics Inc
CORT
|
BUY |
$78.00
Est. +125%
|
$34.71 | $117.33 |
Target Met
|
$82.91
+138.9%
|
| Jul 22, 2024 |
Verona Pharma Plc - ADR
VRNA
|
BUY |
$37.00
Est. +61%
|
$22.95 | $105.27 |
Target Met
|
$106.91
+365.8%
|
| Jul 08, 2024 |
Morphic Holding Inc
MORF
|
BUY |
$57.00
Est. +2%
|
$55.74 | $57.00 |
Bullseye Hit (±1%)
|
$56.99
+2.2%
|
| Jun 12, 2024 |
Corcept Therapeutics Inc
CORT
|
BUY |
$38.00
Est. +16%
|
$32.79 | $117.33 |
Target Met
|
$82.91
+152.9%
|
| Jun 12, 2024 |
Akero Therapeutics Inc
AKRO
|
BUY |
$56.00
Est. +139%
|
$23.43 | $58.40 |
Target Met
|
$54.65
+133.2%
|
| May 23, 2024 |
Cardiol Therapeutics Inc - Ordinary Shares - Class A
CRDL
|
BUY |
$8.00
Est. +257%
|
$2.24 | $2.63 |
Miss
|
$1.03
-54.0%
|
| Mar 27, 2024 |
Rani Therapeutics Holdings Inc - Ordinary Shares Class A
RANI
|
BUY |
$9.00
Est. +183%
|
$3.18 | $4.19 |
Miss
|
$0.76
-76.1%
|
| Jun 29, 2023 |
Intercept Pharmaceuticals Inc
ICPT
|
BUY |
$19.00
Est. +74%
|
$10.90 | $19.01 |
Bullseye Hit (±1%)
|
$19.00
+74.3%
|
| Aug 15, 2022 |
ChemoCentryx Inc
CCXI
|
BUY |
$81.00
Est. +60%
|
$50.72 | $51.98 |
Miss
|
$10.22
-79.9%
|
Connect Biopharma Holdings Ltd - ADR
CNTB
May 26, 2026
Signal & Target
BUY
$6.00
Start Price
$2.35
Best Price (1Y)
$2.72
Current Price
$2.12
Return
-9.8%
Kymera Therapeutics Inc
KYMR
May 06, 2026
Signal & Target
BUY
$106.00
Start Price
$82.71
Best Price (1Y)
$89.46
Current Price
$86.21
Return
+4.2%
Ventyx Biosciences Inc
VTYX
Jan 08, 2026
Signal & Target
BUY
$14.00
Start Price
$13.73
Best Price (1Y)
$14.07
Current Price
$14.00
Return
+2.0%
Corcept Therapeutics Inc
CORT
Jan 02, 2026
Signal & Target
BUY
$99.00
Start Price
$36.90
Best Price (1Y)
$84.79
Current Price
$82.91
Return
+124.7%
Viking Therapeutics Inc
VKTX
Nov 12, 2025
Signal & Target
BUY
$107.00
Start Price
$40.60
Best Price (1Y)
$43.15
Current Price
$28.75
Return
-29.2%
Viking Therapeutics Inc
VKTX
Oct 29, 2025
Signal & Target
BUY
$106.00
Start Price
$34.93
Best Price (1Y)
$43.15
Current Price
$28.75
Return
-17.7%
Madrigal Pharmaceuticals Inc
MDGL
May 02, 2025
Signal & Target
BUY
$420.00
Start Price
$315.48
Best Price (1Y)
$615.00
Current Price
$480.77
Return
+52.4%
Corcept Therapeutics Inc
CORT
Aug 15, 2024
Signal & Target
BUY
$78.00
Start Price
$34.71
Best Price (1Y)
$117.33
Current Price
$82.91
Return
+138.9%
Verona Pharma Plc - ADR
VRNA
Jul 22, 2024
Signal & Target
BUY
$37.00
Start Price
$22.95
Best Price (1Y)
$105.27
Current Price
$106.91
Return
+365.8%
Morphic Holding Inc
MORF
Jul 08, 2024
Signal & Target
BUY
$57.00
Start Price
$55.74
Best Price (1Y)
$57.00
Current Price
$56.99
Return
+2.2%
Corcept Therapeutics Inc
CORT
Jun 12, 2024
Signal & Target
BUY
$38.00
Start Price
$32.79
Best Price (1Y)
$117.33
Current Price
$82.91
Return
+152.9%
Akero Therapeutics Inc
AKRO
Jun 12, 2024
Signal & Target
BUY
$56.00
Start Price
$23.43
Best Price (1Y)
$58.40
Current Price
$54.65
Return
+133.2%
Signal & Target
BUY
$8.00
Start Price
$2.24
Best Price (1Y)
$2.63
Current Price
$1.03
Return
-54.0%
Signal & Target
BUY
$9.00
Start Price
$3.18
Best Price (1Y)
$4.19
Current Price
$0.76
Return
-76.1%
Intercept Pharmaceuticals Inc
ICPT
Jun 29, 2023
Signal & Target
BUY
$19.00
Start Price
$10.90
Best Price (1Y)
$19.01
Current Price
$19.00
Return
+74.3%
ChemoCentryx Inc
CCXI
Aug 15, 2022
Signal & Target
BUY
$81.00
Start Price
$50.72
Best Price (1Y)
$51.98
Current Price
$10.22
Return
-79.9%